BioSpace News Archive

RDD Pharma Raises $9.5M in Series B Funding to Fuel Global Development

RDD Pharma has raised $9.5M in Series B funding, including $6M from two new investors, Pharmascience and an international life science fund, as well as existing investors OrbiMed and Capital Point.

November 16, 2017

·

2 min read

Drug Development

AcelRx Pharma Reports Publication of Manuscript Analyzing Sufentanil Sublingual Tablets in Patients With Postoperative Pain

Conclusions of the study highlighted that sufentanil sublingual tablet 30 mcg was effective and well-tolerated for the management of moderate-to-severe acute pain following a variety of surgical procedures, including knee replacement, open-abdominal surgery and bunionectomy.

November 16, 2017

·

6 min read

Drug Development

Medicenna Presents Updates on Phase IIb Clinical Trial of MDNA55 at the Annual Meeting of the Society of Neuro-Oncology

MDNA55, is the Company’s lead immunotherapeutic agent targeting the interleukin-4 receptor which is known to be over-expressed in brain tumors and the tumor micro-environment but not in healthy brain tissue.

November 16, 2017

·

5 min read

Biotech Beach

MabVax Therapeutics Regains Compliance With Nasdaq’s Minimum Stockholders’ Equity Listing Requirements

The Company regained compliance with the stockholders’ equity requirement as a result of the completion of successful financings totaling $4.75M during the third quarter of 2017.

November 16, 2017

·

3 min read

Policy

TSO3 Provides Duodenoscope Regulatory Filing Update

TSO3 announced today that it has responded to the recent request for additional information (AI), from the FDA.

November 16, 2017

·

4 min read